Description
(±)-MDA (hydrochloride) (CRM) (Item No. ISO60189) is a certified reference material that is structurally categorized as an amphetamine. Tablets sold as ‘‘ecstasy’’ often contain (±)-MDA instead of 3,4-MDMA (Item Nos.
ISO60190 |
13971). (±)-MDA (hydrochloride) is regulated as a Schedule I compound in the United States. (±)-MDA (hydrochloride) (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References
[1] R. DE LA TORRE. Non-linear pharmacokinetics of MDMA (‘ecstasy’) in humans[J]. British journal of clinical pharmacology, 2002, 49 2: 104-109. DOI:
10.1046/j.1365-2125.2000.00121.x[2] ADAM L. HALBERSTADT . Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species[J]. Neuropharmacology, 2020, 167: Article 107933. DOI:
10.1016/j.neuropharm.2019.107933[3] JACK YUK KI CHENG. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography–mass spectrometry[J]. Forensic science international, 2006, 162 1: Pages 87-94. DOI:
10.1016/j.forsciint.2006.02.055
